In Vitro and In Vivo evaluation of a hydrogel-based microneedle device for transdermal electro-modulated analgesia

S. Indermun, Y.E. Choonara, P. Kumar, L.C. du Toit, G. Modi, R. Luttge, M. Govender, V. Pillay

Research output: Contribution to journalArticleAcademicpeer-review

1 Citation (Scopus)

Abstract

With a significant portion of the world suffering from chronic pain, the management and treatment of this condition still requires extensive research to successfully mobilize and functionalize its sufferers. This article details the in vitro and in vivo evaluation of a transdermal electro-modulated hydrogel-microneedle array (EMHM) device for the treatment of chronic pain. In vitro characterization of the electro-modulated hydrogel was undertaken before the determination of the in vivo release, histopathologic and pharmacokinetic profiles of the EMHM in a Sprague Dawley rat model. Pharmacokinetic modeling was conducted to establish a level A in vitro-in vivo correlation. Data analysis was carried out by segmenting the combined in vivo release profile into individualistic profiles before analysis.

LanguageEnglish
Pages1111–1116
Number of pages6
JournalEuropean Journal of Pharmaceutical Sciences
Volume106
Issue number4
DOIs
StatePublished - 2017

Fingerprint

Hydrogel
Analgesia
Chronic Pain
Equipment and Supplies
Pharmacokinetics
Pain Management
Sprague Dawley Rats
Therapeutics
Research
In Vitro Techniques

Keywords

  • Hydrogels
  • IVIVC
  • Pharmacokinetics
  • Responsive drug delivery
  • Skin
  • Transdermal drug delivery

Cite this

Indermun, S. ; Choonara, Y.E. ; Kumar, P. ; du Toit, L.C. ; Modi, G. ; Luttge, R. ; Govender, M. ; Pillay, V./ In Vitro and In Vivo evaluation of a hydrogel-based microneedle device for transdermal electro-modulated analgesia. In: European Journal of Pharmaceutical Sciences. 2017 ; Vol. 106, No. 4. pp. 1111–1116
@article{27ed6f0b759b409da62e47f3b0336b74,
title = "In Vitro and In Vivo evaluation of a hydrogel-based microneedle device for transdermal electro-modulated analgesia",
abstract = "With a significant portion of the world suffering from chronic pain, the management and treatment of this condition still requires extensive research to successfully mobilize and functionalize its sufferers. This article details the in vitro and in vivo evaluation of a transdermal electro-modulated hydrogel-microneedle array (EMHM) device for the treatment of chronic pain. In vitro characterization of the electro-modulated hydrogel was undertaken before the determination of the in vivo release, histopathologic and pharmacokinetic profiles of the EMHM in a Sprague Dawley rat model. Pharmacokinetic modeling was conducted to establish a level A in vitro-in vivo correlation. Data analysis was carried out by segmenting the combined in vivo release profile into individualistic profiles before analysis.",
keywords = "Hydrogels, IVIVC, Pharmacokinetics, Responsive drug delivery, Skin, Transdermal drug delivery",
author = "S. Indermun and Y.E. Choonara and P. Kumar and {du Toit}, L.C. and G. Modi and R. Luttge and M. Govender and V. Pillay",
year = "2017",
doi = "10.1016/j.xphs.2016.12.022",
language = "English",
volume = "106",
pages = "1111–1116",
journal = "European Journal of Pharmaceutical Sciences",
issn = "0928-0987",
publisher = "Elsevier",
number = "4",

}

Indermun, S, Choonara, YE, Kumar, P, du Toit, LC, Modi, G, Luttge, R, Govender, M & Pillay, V 2017, 'In Vitro and In Vivo evaluation of a hydrogel-based microneedle device for transdermal electro-modulated analgesia' European Journal of Pharmaceutical Sciences, vol. 106, no. 4, pp. 1111–1116. DOI: 10.1016/j.xphs.2016.12.022

In Vitro and In Vivo evaluation of a hydrogel-based microneedle device for transdermal electro-modulated analgesia. / Indermun, S.; Choonara, Y.E.; Kumar, P.; du Toit, L.C.; Modi, G.; Luttge, R.; Govender, M.; Pillay, V.

In: European Journal of Pharmaceutical Sciences, Vol. 106, No. 4, 2017, p. 1111–1116.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - In Vitro and In Vivo evaluation of a hydrogel-based microneedle device for transdermal electro-modulated analgesia

AU - Indermun,S.

AU - Choonara,Y.E.

AU - Kumar,P.

AU - du Toit,L.C.

AU - Modi,G.

AU - Luttge,R.

AU - Govender,M.

AU - Pillay,V.

PY - 2017

Y1 - 2017

N2 - With a significant portion of the world suffering from chronic pain, the management and treatment of this condition still requires extensive research to successfully mobilize and functionalize its sufferers. This article details the in vitro and in vivo evaluation of a transdermal electro-modulated hydrogel-microneedle array (EMHM) device for the treatment of chronic pain. In vitro characterization of the electro-modulated hydrogel was undertaken before the determination of the in vivo release, histopathologic and pharmacokinetic profiles of the EMHM in a Sprague Dawley rat model. Pharmacokinetic modeling was conducted to establish a level A in vitro-in vivo correlation. Data analysis was carried out by segmenting the combined in vivo release profile into individualistic profiles before analysis.

AB - With a significant portion of the world suffering from chronic pain, the management and treatment of this condition still requires extensive research to successfully mobilize and functionalize its sufferers. This article details the in vitro and in vivo evaluation of a transdermal electro-modulated hydrogel-microneedle array (EMHM) device for the treatment of chronic pain. In vitro characterization of the electro-modulated hydrogel was undertaken before the determination of the in vivo release, histopathologic and pharmacokinetic profiles of the EMHM in a Sprague Dawley rat model. Pharmacokinetic modeling was conducted to establish a level A in vitro-in vivo correlation. Data analysis was carried out by segmenting the combined in vivo release profile into individualistic profiles before analysis.

KW - Hydrogels

KW - IVIVC

KW - Pharmacokinetics

KW - Responsive drug delivery

KW - Skin

KW - Transdermal drug delivery

UR - http://www.scopus.com/inward/record.url?scp=85010973253&partnerID=8YFLogxK

U2 - 10.1016/j.xphs.2016.12.022

DO - 10.1016/j.xphs.2016.12.022

M3 - Article

VL - 106

SP - 1111

EP - 1116

JO - European Journal of Pharmaceutical Sciences

T2 - European Journal of Pharmaceutical Sciences

JF - European Journal of Pharmaceutical Sciences

SN - 0928-0987

IS - 4

ER -